Shareholders

Investigation Launched into Ibotta, Inc. for Alleged Misleading Financial Disclosures; Shareholders Might Be Compensated

by

New York, NY — The internationally recognized investor rights law firm, Rosen Law Firm, is currently investigating potential securities claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). This investigation follows allegations that Ibotta might have provided the investing public with significantly misleading business information. Shareholders who purchased securities in Ibotta could potentially receive compensation through a contingency fee arrangement, meaning they would not face any out-of-pocket fees or costs. Rosen Law Firm is in the process of assembling a class action lawsuit to pursue recovery of investor losses. To become a member of … Read more

Zynex, Inc. (ZYXI) Shareholders: Explore Your Options in Ongoing Securities Fraud Investigation with Howard G. Smith Law Offices

by

Broomfield, Colorado – Shareholders who have incurred financial losses from their investments in Zynex, Inc. (ZYXI), a medical technology company, are being alerted to a developing securities fraud investigation. The Law Offices of Howard G. Smith is spearheading the probe amidst concerns surrounding alleged misleading statements and potentially unlawful business practices that might have skewed the company’s stock valuation. Zynex, known for manufacturing non-invasive medical devices for pain management, rehabilitation, and electrotherapy, recently came under scrutiny. The investigation by the Law Offices of Howard G. Smith focuses primarily on whether the company or its executives … Read more

SMTC Shareholders Called to Spearhead Semtech Corporation Securities Fraud Class Action

by

Cambridge, Massachusetts – Investors who have put their money into Semtech Corporation are now given the chance to spearhead a class-action lawsuit over alleged securities fraud. This legal maneuver follows claims that the company may have misled shareholders about financial performance and business prospects. The lawsuit aims to address potential financial discrepancies during a specific period, from March 17, 2021, to December 7, 2022. During this time, it is alleged that Semtech failed to fully disclose various financial struggles, notably linked to its capabilities in managing supply chain challenges, thereby seemingly inflating its stock market … Read more

Investors Alert: Join Pacira BioSciences Class Action Lawsuit by March 14, 2025 – Legal Representation Available Through The Gross Law Firm for PCRX Shareholders

by

Investors in Pacira BioSciences, Inc. are facing critical financial concerns following allegations of securities fraud, prompting a class action lawsuit that demands immediate attention. With a deadline of March 14, 2025, for Pacira’s shareholders to contact The Gross Law Firm to discuss their legal options, time is of the essence for those impacted by the company’s recent stock performance issues. Pacira BioSciences, known for its non-opioid pain management drugs, has come under legal scrutiny after accusations surfaced that the company may have misled investors about its business and financial prospects. These allegations suggest that Pacira … Read more